Pages that link to "Q28284394"
The following pages link to Accumulation of glucosylceramides in multidrug-resistant cancer cells (Q28284394):
Displaying 50 items.
- Killing tumours by ceramide-induced apoptosis: a critique of available drugs (Q24529892) (← links)
- Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis (Q24537114) (← links)
- Galactosylceramide affects tumorigenic and metastatic properties of breast cancer cells as an anti-apoptotic molecule (Q27335599) (← links)
- Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications (Q28084270) (← links)
- A new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosis (Q28476087) (← links)
- Metabolomics coupled with multivariate data and pathway analysis on potential biomarkers in gastric ulcer and intervention effects of Corydalis yanhusuo alkaloid (Q28538684) (← links)
- Extended ultrastructural characterization of chordoma cells: the link to new therapeutic options (Q28542546) (← links)
- Trafficking of ganglioside GD3 to mitochondria by tumor necrosis factor-alpha (Q28572338) (← links)
- Dynamics of ceramide generation and metabolism in response to fenretinide--Diversity within and among leukemia (Q30278944) (← links)
- Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia--Impact on enzyme activity and response to cytotoxics (Q30300370) (← links)
- Differential expression of sphingolipids in MRP1 overexpressing HT29 cells (Q30881625) (← links)
- Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice (Q30881683) (← links)
- Re-configuration of sphingolipid metabolism by oncogenic transformation (Q33649823) (← links)
- Glucosylceramide synthase, a factor in modulating drug resistance, is overexpressed in metastatic breast carcinoma (Q33683147) (← links)
- Changes in membrane microdomains and caveolae constituents in multidrug-resistant cancer cells (Q33695154) (← links)
- Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance (Q33733991) (← links)
- Augmentation of therapeutic efficacy in drug-resistant tumor models using ceramide coadministration in temporal-controlled polymer-blend nanoparticle delivery systems (Q33749449) (← links)
- Expanding spectrum of the association between Type 1 Gaucher disease and cancers: a series of patients with up to 3 sequential cancers of multiple types--correlation with genotype and phenotype (Q33874873) (← links)
- Ganglioside synthase knockout in oncogene-transformed fibroblasts depletes gangliosides and impairs tumor growth (Q33893675) (← links)
- Recent developments in the cell biology and biochemistry of glycosylphosphatidylinositol lipids (review). (Q33902904) (← links)
- Glucosylceramide synthase does not attenuate the ceramide pool accumulating during apoptosis induced by CD95 or anti-cancer regimens (Q33914230) (← links)
- Sphingolipid transport in eukaryotic cells. (Q33944782) (← links)
- Caveolin-1: a tumor-promoting role in human cancer (Q34010128) (← links)
- Multidrug resistance: a role for cholesterol efflux pathways? (Q34085592) (← links)
- Caveolae: an alternative membrane transport compartment (Q34087280) (← links)
- Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases (Q34129373) (← links)
- Lipid membrane domains in cell surface and vacuolar systems (Q34153450) (← links)
- Changes in lipid and protein constituents of rafts and caveolae in multidrug resistant cancer cells and their functional consequences (Q34153467) (← links)
- Cancer chemotherapy--ribonucleases to the rescue (Q34254671) (← links)
- Traveling for the glycosphingolipid path (Q34290912) (← links)
- Cytoprotective effect of glucosylceramide synthase inhibition against daunorubicin-induced apoptosis in human leukemic cell lines (Q34295244) (← links)
- Gene interaction enrichment and network analysis to identify dysregulated pathways and their interactions in complex diseases (Q34302997) (← links)
- Ceramide regulates cellular homeostasis via diverse stress signaling pathways (Q34323738) (← links)
- Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells (Q34334511) (← links)
- Upregulation of caveolin in multidrug resistant cancer cells: functional implications (Q34365159) (← links)
- Apoptotic Sphingolipid Ceramide in Cancer Therapy (Q34736760) (← links)
- Sphingolipids in neuroblastoma: their role in drug resistance mechanisms (Q34955797) (← links)
- Cancer progression in the kidney and prostate: vital roles of sphingolipids in chemotherapy (Q34973880) (← links)
- Glucosylceramide synthase and apoptosis (Q35047165) (← links)
- P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells. (Q35057879) (← links)
- Designing anticancer drugs via the achilles heel: ceramide, allylic ketones, and mitochondria (Q35114241) (← links)
- Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics (Q35324757) (← links)
- Raft ceramide in molecular medicine (Q35559152) (← links)
- Increase in docetaxel-resistance of ovarian carcinoma-derived RMG-1 cells with enhanced expression of Lewis Y antigen (Q35600076) (← links)
- Glycosphingolipids and cell death (Q35671116) (← links)
- Colon cancer: genomics and apoptotic events (Q35837213) (← links)
- Biologically active sphingolipids in cancer pathogenesis and treatment (Q35852313) (← links)
- Glycosphingolipids and mitochondria: role in apoptosis and disease. (Q35904273) (← links)
- Strategies for overcoming p-glycoprotein-mediated drug resistance in acute myeloblastic leukaemia (Q35918060) (← links)
- Reticulon Protein-1C: A New Hope in the Treatment of Different Neuronal Diseases (Q36010989) (← links)